-
公开(公告)号:US20230190719A1
公开(公告)日:2023-06-22
申请号:US17923585
申请日:2021-06-23
IPC分类号: A61K31/4402 , A61K9/00 , A61K45/06 , A61K47/44
CPC分类号: A61K31/4402 , A61K9/0014 , A61K45/06 , A61K47/44
摘要: Provided is a pharmaceutical formulation including (1S)-1-phenyl-2-pyridin-2-ylethanamine, a pharmaceutically acceptable salt thereof, a solvate thereof, or a prodrug thereof; and a pharmaceutically acceptable topical carrier. Also provided is a method for treating neuropathic pain by administering to a patient in need of such treatment a therapeutically effective amount of the pharmaceutical formulation.
-
公开(公告)号:US20230181541A1
公开(公告)日:2023-06-15
申请号:US17923587
申请日:2021-06-24
发明人: Vladimir CORIC , Robert BERMAN , Loren AGUIAR
IPC分类号: A61K31/428 , A61P25/18
CPC分类号: A61K31/428 , A61P25/18
摘要: Disclosed herein is a method for treating obsessive-compulsive disorder in a patient in need thereof by administering to the patient a dosage form including an effective amount of troriluzole.
-
公开(公告)号:US20240082340A1
公开(公告)日:2024-03-14
申请号:US18261419
申请日:2022-01-17
发明人: Vladimir CORIC , Robert BERMAN
CPC分类号: A61K38/06 , A61K9/485 , A61K9/4858 , A61K9/4866 , A61P25/28
摘要: Disclosed are methods of treating a patient afflicted with Alzheimer's Disease of mild-to-moderate severity by administering to the patient a riluzole prodrug. Pharmaceutical compositions and kits including the riluzole prodrugs are also disclosed.
-
公开(公告)号:US20230390252A1
公开(公告)日:2023-12-07
申请号:US18353840
申请日:2023-07-17
IPC分类号: A61K31/428 , A61P25/00
CPC分类号: A61K31/428 , A61P25/00 , A61K9/20
摘要: Disclosed are methods of treating ataxia by administering to a patient in need thereof a riluzole prodrug such as troriluzole. Pharmaceutical compositions and kits including the riluzole prodrugs are also disclosed.
-
公开(公告)号:US20230355592A1
公开(公告)日:2023-11-09
申请号:US18353850
申请日:2023-07-17
IPC分类号: A61K31/428 , A61P25/00
CPC分类号: A61K31/428 , A61P25/00 , A61K9/20
摘要: Disclosed are methods of treating ataxia by administering to a patient in need thereof a riluzole prodrug such as troriluzole. Pharmaceutical compositions and kits including the riluzole prodrugs are also disclosed.
-
-
-
-